Discover
BIAF
bioAffinity Technologies, Inc.
0.84
2 x 0.58
2 x 1.07
bid
ask
+
0.03
3.88%
2 @ 04:00 PM
0.83 -0.02 (1.79%)
| Ytd | -28.52% | |
| 1y | -89.35% |
0.81
day range
0.85
0.69
52 week range
13.50
| Open | 0.84 | Prev Close | 0.81 | Low | 0.81 | High | 0.85 | Mkt Cap | 5.30M |
| Vol | 485.91K | Avg Vol | 465.42K | EPS | -4.67 | P/E | N/A | Forward P/E | -1.58 |
| Beta | 3.12 | Short Ratio | 1.43 | Inst. Own | 3.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.67 | 200-d Avg | 2.08 | 1yr Est | 6.00 |
BIAF News
benzinga.com
bioAffinity To Present Preclinical Findings For Therapeutic Approach That Uses siRNAs That Kill Squa
Research suggests a potential topical treatment for common skin cancers, squamous cell and basal cel
benzinga.com
bioAffinity Technologies Prices $3.2M Offering Of 4M Shares (Or Pre-funded Warrants) At $0.80/Share
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need fo
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session